Sort
130,381 grants matching “hiv”
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,227,889Rafick-Pierre Sekaly · Emory University · P01 · FY2025 · AI
A novel vaccine against multidrug-resistant gonorrhea
$1,227,829Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
$1,227,827Sallie R. Permar · Duke University · P01 · FY2020 · AI
Molecular Biology Of Retroviruses Associated With AIDS
$1,227,557Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
University of California, San Diego Clinical Trial Unit
$1,227,553Stephen A Spector · University Of California, San Diego · UM1 · FY2013 · AI
Cornell Clinical Trials Unit
$1,227,503Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2011 · AI
Mechanisms Of Humoral Evasion
$1,227,402Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Randomized Control Trial of Positive Peers mHealth app as a clinic-based intervention to optimize HIV outcomes among young, minority persons living with HIV
$1,227,205Ann K Avery · Case Western Reserve University · R01 · FY2023 · MD
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$1,226,902Shruti H Mehta · Johns Hopkins University · R01 · FY2015 · DA
The Impact of Early Medical Treatment in Transgender Youth
$1,226,865Johanna L Olson-Kennedy · Children'S Hospital Of Los Angeles · R01 · FY2017 · HD
Herpesviruses as Vaccine Vectors for AIDS
$1,226,620David M Knipe · Harvard Medical School · P01 · FY2008 · AI
Seattle-Lausanne Clinical Trials Unit
$1,226,577Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
HARLEM AIDS TREATMENT GROUP-'CPCRA'
$1,226,527Columbia University Health Sciences · U01 · FY2002 · AI
START Together: HIV Testing and Treatment in and after Jail
$1,226,504Stanley Sacks · National Development And Research Institutes, Inc. · R01 · FY2010 · DA
An immune-based approach for HIV eradication
$1,226,363Juan Lama · Retrovirox, Inc. · R44 · FY2016 · AI
Effects of systemic and topical perturbations on human microbes
$1,225,978Heidi Kong · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,225,767Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2023 · CA
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2023 · HD
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2021 · HD
Clinical evaluation of SARS-CoV-2 subunit vaccine in a Phase I human clinical study
$1,225,641Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2020 · AI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,614Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2020 · HD
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,225,410Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2017 · CA
Project 1: Rational design of targeted vaccines to induce HIV V2-apex bnAb responses
$1,225,307Raiees Ahmad Andrabi · University Of Pennsylvania · U19 · FY2025 · AI
LC - IMPAACT Leadership Group
$1,225,138Grace M. Aldrovandi · Children'S Hospital Of Los Angeles · UM1 · FY2016 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,225,136University Of Alabama At Birmingham · U01 · FY2002 · AI